Your browser doesn't support javascript.
loading
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Sauter, Craig S; Matasar, Matthew J; Schoder, Heiko; Devlin, Sean M; Drullinsky, Pamela; Gerecitano, John; Kumar, Anita; Noy, Ariela; Palomba, Maria L; Portlock, Carol S; Straus, David J; Zelenetz, Andrew D; McCall, Susan J; Miller, Shoshana T; Courtien, Amanda I; Younes, Anas; Moskowitz, Craig H.
Affiliation
  • Sauter CS; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Matasar MJ; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Schoder H; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Devlin SM; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Drullinsky P; Molecular Imaging and Therapy Service, Department of Radiology, and.
  • Gerecitano J; Department of Epidemiology and Biostatistics, MSKCC, New York, NY.
  • Kumar A; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Noy A; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Palomba ML; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Portlock CS; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Straus DJ; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Zelenetz AD; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • McCall SJ; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Miller ST; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Courtien AI; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Younes A; Department of Medicine, Weill Cornell Medical College, New York, NY; and.
  • Moskowitz CH; Lymphoma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
Blood ; 131(16): 1805-1808, 2018 04 19.
Article in En | MEDLINE | ID: mdl-29386196
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article